Business
NBA looks to China for growth, renewing a foothold in its second-largest market
Michael Porter Jr. #17 of the Brooklyn Nets shoots the ball during practice and media availability as part of 2025 NBA Global Games China at Venetian Arena on October 9, 2025 in Macao, China.
Ryan Stetz | National Basketball Association | Getty Images
MACAO — The National Basketball Association returns to China for the first of two Macao games on Friday, and the impact extends beyond the preseason.
The weekend marks a major milestone for the NBA, as years of rebuilding its relationship with its second-largest market culminate with the Phoenix Suns and Brooklyn Nets facing off in the Venetian Arena here. For the NBA, it could mean unlocking future growth in China as television viewership declines in the U.S.
The NBA’s return to China comes after a six-year hiatus following 2019 comments by Daryl Morey, then-Houston Rockets general manager, voicing support for Hong Kong protestors and setting off an international crisis. For the next three years, the league was largely absent from Chinese airwaves in China. Nearly every Chinese sponsor cut ties with the NBA.
But the NBA’s history in China dates back to the 1970s. Since 1979, the NBA and USA basketball have played a total of 48 games in China, according to NBA data. Demand for the 2025 Macao games, set for Friday and Sunday, was high: At the upper end, tickets were going for more than $3,000.
And there are signs of progress off the court, too.
The league on Thursday announced a renewed partnership with Alibaba, making the tech company’s cloud unit the official cloud computing and AI partner of NBA China. The partnership already included a dedicated NBA section across Alibaba platforms that allow fans in China to engage in content or shop for NBA merchandise.
Alibaba chairman Joe Tsai owns the Nets.
The NBA is hoping to tap into basketball fans among China’s 1.4 billion-person population as the league grapples with cord-cutting and changing viewership habits at home. Last season, television viewership dipped.
Meanwhile, in China, the NBA has won a massive fan base. It’s the most-followed sports league on social media, according to the league, with 425 million followers across league, team and player platforms. To put that number in perspective, that’s more than the entire population of the United States.
The league has also been investing in infrastructure in China. It now has four flagship stores, 45 NBA kids stores, seven NBA e-commerce flagship stores and more than 5,000 partner retail stores across the country.
“We’ve created a lot of fan experiences here, and the goal is to really make something special where the fans of the NBA in Asia and China can really get a true taste of what the NBA has to offer,” said Patrick Dumont, Dallas Mavericks owner and Las Vegas Sands president, who was an architect of the NBA’s return to China. Las Vegas Sands owns the Venetian in Macao, where the two preseason games will be played.
To raise awareness and give back to the local communities, the league has hosted more than 140 community outreach events and built 100 spaces for children and family to learn, live and play in China since 2004. More than 400 current and former NBA players have participated in this program.
This week, the Nets are hosting 13 youth clinics across Hong Kong and Macao, in addition to a basketball court refurbishment project in Hong Kong.
It’s not just at the league level where professional basketball is tapping into China’s potential. At least seven NBA teams and 10 individual players are working with East Goes Global, a marketing and consulting firm that bridges the western brands with Chinese audiences.
“We’re able to localize a ton of their western-facing content, creating new, unique content, even showing up to a lot of the team’s media days to shoot China specific content,” said Andrew Spalter, founder and CEO of the company.
East Goes Global, run by brothers Andrew and Matthew Spalter, also works directly with New York Knicks star Jalen Brunson to grow his international profile in China.
“Jalen is actively speaking to his Chinese audience more so than most athletes have ever done in the past. He’s trying to learn calligraphy, he’s eating Chinese foods, he’s collaborating with Chinese influencers and celebrities,” said Matthew Spalter, chief operating officer at East Goes Global.
Dumont said the Macao games are part of a multi-year deal and that executives are already thinking about next year.
“I think it’s the classic win, win, win,” he said. “It’s great for the NBA because it gets to bring its best product, top teams, real games, real experiences, and it allows local fans who maybe don’t have the ability to get to the U.S. to get to experience the NBA and see basketball played at the highest level.”
1729471601-0/image-(8)1729471601-0-640x480.webp "Pakistan’s crisis differs from world | The Express Tribune")
The Eli Lilly logo appears on the company’s office in San Diego, California, U.S., Nov. 21, 2025.
Mike Blake | Reuters
Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect, building on efforts by the company and the Trump administration to make the medicine more accessible.
The announcement also comes weeks after chief rival Novo Nordisk unveiled additional discounts on the cash prices of its obesity and diabetes drugs.
Starting Monday, cash-paying patients with a valid prescription can get the starting dose of Zepbound vials for as low as $299 per month on LillyDirect, down from a previous price of $349 per month. They can also access the next dose, 5 milligrams, for $399 per month and all other doses for $449 per month, down from $499 per month across those sizes.
Zepbound carries a list price of roughly $1,086 per month. That price point, and spotty insurance coverage for weight loss drugs in the U.S., have been significant barriers to access for some patients.
Eli Lilly’s announcement comes just weeks after President Donald Trump inked deals with Eli Lilly and Novo Nordisk to make their GLP-1 drugs easier for Americans to get and afford. The agreements will cut the prices the government pays for the drugs, introduce Medicare coverage of obesity drugs for the first time for certain patients and offer discounted medicines on the government’s new direct-to-consumer website launching in January, TrumpRx.
But Eli Lilly’s deal with Trump centers around lowering the prices of a different form of Zepbound – a multi-dose pen – after it wins Food and Drug Administration approval.
That means Eli Lilly’s Monday announcement around cutting prices on the existing single-dose vials could allow more patients to get discounted treatments more quickly.
“We will keep working to provide more options — expanding choices for delivery devices and creating new pathways for access — so more people can get the medicines they need,” said Ilya Yuffa, president of Lilly USA and global customer capabilities, in a statement.
Eli Lilly’s stock, which has climbed more than 36% this year, fell nearly 2% on Monday. Its meteoric rise due to the success of Zepbound and its diabetes injection Mounjaro vaulted it to becoming the first health-care company to hit a $1 trillion market value last month. Though cutting prices means lower revenue per medication sold, Eli Lilly’s sales — and shares — have continued to soar through past pricing announcements as demand balloons.
With single-dose vials, patients need to use a syringe and needle to draw up the medicine and inject it into themselves. Eli Lilly first introduced that form of Zepbound in August 2024.
It’s unclear how many patients are currently using single-dose vials of Zepbound. But Eli Lilly previously said that direct-to-consumer sales now account for more than a third of new prescriptions of Zepbound.
Novo Nordisk earlier this month lowered the price of its obesity drug Wegovy and diabetes treatment Ozempic for existing cash-paying patients to $349 per month from $499 per month. That excludes the highest dose of Ozempic.
The company also launched a temporary introductory offer, which will allow new cash-paying patients to access the two lowest doses of Wegovy and Ozempic for $199 per month for the first two months of treatment.
The Oil and Gas Regulatory Authority (OGRA) has approved a fresh increase in the price of liquefied petroleum gas (LPG), raising the cost for both domestic consumers and commercial users.
According to the notification issued, the LPG price has been increased by Rs7.39 per kilogram, setting the new rate at Rs209 per kg for December. As a result, the price of a domestic LPG cylinder has risen by Rs87.21, bringing the new price to Rs2,466.10.
In November, the price of LPG stood at Rs201 per kg, while the domestic cylinder was priced at Rs2,378.89.
The latest price hike is expected to put additional pressure on households already grappling with rising living costs nationwide.
New Delhi: The taxable value of all supplies under GST surged by a robust 15 per cent during September-October this year, compared to the same period in 2024 due to sharp increase in consumption triggered by the tax rate cuts on goods across sectors that kicked in from September 22, according to official sources.
The growth in the same two-month period last year was 8.6 per cent. “This surge in taxable value during ‘Bachat Utsav’ demonstrates strong consumption uplift, stimulated by reduced rates and improved compliance behaviour,” a senior official said.
He pointed out that the growth has especially been strong in sectors where rate rationalisation was implemented, such as FMCG, pharma goods, food products, automobiles, medical devices and textiles. In these sectors, the taxable value of supplies has seen significantly higher growth, confirming that lower GST rates translated directly into higher consumer spending.
“It vindicates our strategy that reducing rates on essentials and mass-use sectors would create demand-side buoyancy — a Laffer Curve–type demand uplift,” he explained.These trends confirm that GST next-gen reforms have not disrupted revenue stability, and that consumption-side buoyancy has begun to translate into higher taxable value in key sectors.
This growth is in value terms which means that since GST rates were lower, the growth in volume terms will be even higher. It is clearly visible that while the Next Gen Reforms resulted in significant Bachat — increased consumption, industry has been very proactive in passing on the GST savings to the final consumers and ensuring that there is no supply side deficiency.
As GDP private consumption data will be released much later, GST taxable value serves as the most reliable real-time proxy for consumption, and the current numbers clearly indicate sustained demand expansion, the official added.
Eli Lilly cuts cash prices of Zepbound weight loss drug vials on direct-to-consumer site
Geoffrey Boycott advises England to ‘use brains’ for Ashes remainder
Wake Up—the Best Cyber Monday Mattress and Bedding Sales Are Here
-
Sports1 week agoWATCH: Ronaldo scores spectacular bicycle kick
-
Entertainment1 week agoWelcome to Derry’ episode 5 delivers shocking twist
-
Politics1 week agoWashington and Kyiv Stress Any Peace Deal Must Fully Respect Ukraine’s Sovereignty
-
Business1 week agoKey economic data and trends that will shape Rachel Reeves’ Budget
-
Politics1 week ago53,000 Sikhs vote in Ottawa Khalistan Referendum amid Carney-Modi trade talks scrutiny
-
Tech6 days agoWake Up—the Best Black Friday Mattress Sales Are Here
-
Fashion1 week agoCanada’s Lululemon unveils team Canada kit for Milano Cortina 2026
-
Tech1 day agoGet Your Steps In From Your Home Office With This Walking Pad—On Sale This Week